Adminstration Set Docking Station Suppliers
www.baxa.com | Send Inquiry | Phone: +1-(303)-690-4204, 800.567.2292
Year Established: 1975 Annual Revenues: USD 50-100 Million Employee Count: ~50 Quality: ISO 9001, CE Certified
Products: Disinfect & Cleaning Solution, IV Sets, General Diagnostic Equipment, Medical Imaging, General Medical Imaging Accessories, Nursing Computer Software, ...
Baxa Corporation has developed a comprehensive system of products for delivering oral and other non-IV medications precisely and safely to pediatric, adult and geriatric populations. The Rapid-Fill au more...
https://codanargus.com/en | Send Inquiry | Phone: +41-(41)-785 09 44
Products: Syringe Pumps, Syringe Infusion Pump, Pressure Infusor for I.V. Bags (FDA Code: KZD), Adminstration Set Docking Station (FDA Code: ODI), Syringe Pump Sets, Infusion Pumps, ...
Codan Argus Ag specializes in offering syringe pumps. Our syringe pumps are ready for immediate use. We also provide infusion pump. It is suitable for administering large volumes of medication in all more...
An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.
Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled "Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers." Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in 880.9.
